Hansen M F, Koufos A, Gallie B L, Phillips R A, Fodstad O, Brøgger A, Gedde-Dahl T, Cavenee W K
Proc Natl Acad Sci U S A. 1985 Sep;82(18):6216-20. doi: 10.1073/pnas.82.18.6216.
Survivors of the heritable form of retinoblastoma subsequently develop second primary osteosarcomas at substantially greater frequency than either the general population or survivors of nonheritable retinoblastoma. Here we present molecular genetic evidence that the development of these two disparate tumor types involves specific somatic loss of constitutional heterozygosity for the region of human chromosome 13 that includes the RB1 locus. Similar events occur during the genesis of nonheritable osteosarcoma but not in several other embryonal tumors or sarcomas. These findings suggest that a conceptual approach toward defining the number of genes whose recessive mutant forms predispose to cancer is the molecular genetic analysis of clinically associated tumor types. They also suggest that the molecular basis of mixed cancer families may be the differential expression of a single pleiotropic recessive mutation by tissue specific mitotic segregation abnormalities.
遗传性视网膜母细胞瘤的幸存者随后发生第二原发性骨肉瘤的频率,比普通人群或非遗传性视网膜母细胞瘤的幸存者要高得多。在此,我们提供分子遗传学证据表明,这两种不同肿瘤类型的发生涉及人类13号染色体上包括RB1基因座区域的特定体细胞性杂合性缺失。类似事件在非遗传性骨肉瘤发生过程中也会出现,但在其他几种胚胎性肿瘤或肉瘤中则不会。这些发现表明,一种确定其隐性突变形式易患癌症的基因数量的概念性方法,是对临床相关肿瘤类型进行分子遗传学分析。它们还表明,混合癌症家族的分子基础可能是通过组织特异性有丝分裂分离异常导致单个多效性隐性突变的差异表达。